US-based conglomerate General Electric Company has made its first investment out of its new corpo- rate venturing fund with a $5m backing of California-based CardioDx.

The CardioDx investment was made out of the $250m GE Healthymagination fund and is part of a larger round, which a regulatory filing seen by news provider suggests could be worth more than $45.5m.

The GE Healthymagination fund was launched in October to identify and partner healthcare technology companies as part of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?